■ LECTURE OVERVIEW: Hodgkin Lymphoma is a clonal B-cell malignancy characterized by the presence of pathognomonic giant tumor cells in a polymorphic background of reactive immune cells.
■ PATHOGNOMONIC HISTOLOGY & FLOW:
1. Giant Tumor Cells: The diagnostic hallmark is the Reed-Sternberg (RS) cell—a giant cell (20-40 microns) with abundant pale cytoplasm.
2. Owl Eyes: RS cells typically possess a bilobed or multilobed nucleus, with each lobe containing an extraordinarily prominent, acidophilic (pink) nucleolus surrounded by a clear halo, creating a classic 'owl-eye' appearance.
3. B-Cell Rearrangements: Though arising from mutated B-lineage cells in germinal centers, RS cells have lost their classical B-cell surface markers (such as CD20 and surface immunoglobulins).
4. Immunophenotype: Diagnostic RS cells are immunophenotypically positive for CD15 and CD30 but negative for CD45.
■ PHYSIOLOGICAL METABOLIC RECOVERY LOOPS:
Intense pathologic strain initiates systemic arterial, neural, or renal neurohormonal feedback mechanisms to maintain oxygenation, cellular pH balance, and blood pressure in critical territories.
■ PEDIATRIC CONTEXT & CONTINGENCIES:
Developing cohorts present with high body-water percentages and dynamic hepatic enzyme maturation pathways.
[HY-BOARD-1160]
🌟 Dynamic Clinical Key:
Classic Hodgkin Lymphoma peaks in young adults (bimodal age distribution: 15-35 and >55 years). It typically presents with painless cervical lymphadenopathy and systemic 'B symptoms' (fever, night sweats, weight loss) driven by systemic cytokine release from tumor cells. Recognize that blocking some compensatory mechanisms (like reducing hyperventilation in respiratory compensation) can hasten acidotic collapse. Always utilize body-surface-area or weight-based dosing calculators for pediatric populations.